XNYSALC
Market cap41bUSD
Dec 20, Last price
84.76USD
1D
0.69%
1Q
-13.05%
IPO
47.92%
Name
Alcon AG
Chart & Performance
P/E
42.93
P/S
4.14
EPS
1.97
Div Yield, %
0.30%
Shrs. gr., 5y
0.32%
Rev. gr., 5y
7.13%
Revenues
9.46b
+8.47%
Net income
974m
+190.75%
CFO
1.48b
+21.73%
Dividend
May 14, 20240.26441 USD/sh
Earnings
Feb 25, 2025
Profile
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 9,455,000 8.47% | 8,717,000 5.14% | 8,291,000 21.34% | ||||||
Cost of revenue | 5,067,000 | 4,671,000 | 4,481,000 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 4,388,000 | 4,046,000 | 3,810,000 | ||||||
NOPBT Margin | 46.41% | 46.42% | 45.95% | ||||||
Operating Taxes | (142,000) | 128,000 | 42,000 | ||||||
Tax Rate | 3.16% | 1.10% | |||||||
NOPAT | 4,530,000 | 3,918,000 | 3,768,000 | ||||||
Net income | 974,000 190.75% | 335,000 -10.90% | 376,000 -170.81% | ||||||
Dividends | (116,000) | (103,281) | (54,115) | ||||||
Dividend yield | 0.36% | 0.33% | 0.14% | ||||||
Proceeds from repurchase of equity | (49,000) | (50,000) | (22,000) | ||||||
BB yield | 0.15% | 0.16% | 0.06% | ||||||
| Debt | |||||||||
Debt current | 216,000 | 168,000 | 174,000 | ||||||
Long-term debt | 5,335,000 | 5,330,000 | 4,711,000 | ||||||
Deferred revenue | 556,000 | 772,000 | |||||||
Other long-term liabilities | 784,000 | 230,000 | 168,000 | ||||||
Net debt | 4,131,000 | 4,410,000 | 3,255,000 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 1,481,502 | 1,217,000 | 1,345,000 | ||||||
CAPEX | (660,000) | (745,000) | (1,180,000) | ||||||
Cash from investing activities | (1,094,000) | (1,865,000) | (1,198,000) | ||||||
Cash from financing activities | (211,000) | (8,000) | (123,000) | ||||||
FCF | 3,425,914 | 3,496,000 | 3,350,000 | ||||||
| Balance | |||||||||
Cash | 1,101,000 | 980,000 | 1,578,000 | ||||||
Long term investments | 319,000 | 108,000 | 52,000 | ||||||
Excess cash | 947,250 | 652,150 | 1,215,450 | ||||||
Stockholders' equity | 20,617,016 | 19,677,000 | 19,256,000 | ||||||
Invested Capital | 25,606,590 | 24,561,850 | 23,179,550 | ||||||
ROIC | 18.06% | 16.41% | 16.37% | ||||||
ROCE | 16.04% | 15.40% | 14.99% | ||||||
| EV | |||||||||
Common stock shares outstanding | 496,500 | 494,400 | 493,400 | ||||||
Price | 65.64 3.89% | 63.18 -21.75% | 80.74 37.22% | ||||||
Market cap | 32,590,260 4.33% | 31,236,192 -21.59% | 39,837,115 38.45% | ||||||
EV | 36,721,260 | 35,646,192 | 43,092,115 | ||||||
EBITDA | 5,691,252 | 5,169,000 | 5,029,000 | ||||||
EV/EBITDA | 6.45 | 6.90 | 8.57 | ||||||
Interest | 189,000 | 134,000 | 120,000 | ||||||
Interest/NOPBT | 4.31% | 3.31% | 3.15% | ||||||